MRSH Systematic Research
Marsh & McLennan Companies demonstrates exceptional profitability metrics within the insurance brokerage sector, with a return on equity of 25.91% substantially exceeding typical sector benchmarks. The company currently trades at a P/E ratio of 19.77 against a market capitalization of $77.6 billion, while maintaining a net profit margin of 14.26% that reflects strong operational execution. Systematic screening highlights the firm's positioning approximately 30% below its 52-week high of $235.78, as the current price of $165.98 suggests material retracement from recent peaks.
Key fundamental strengths include:
- Revenue growth acceleration to 9.87% year-over-year indicates robust organic expansion in a maturing insurance services market
- Price-to-sales ratio of 2.82 reflects premium valuation relative to asset-light business model characteristics
- Price-to-book value of 5.86 corresponds with high-return profile, as book value per share of $31.14 generates substantial equity returns
- Conservative beta of 0.64 positions the equity as a lower-volatility allocation within financial services portfolios
The model flags concerning earnings dynamics, as EPS declined 2.01% year-over-year to $7.99 despite accelerating revenue growth—a margin compression signal warranting monitoring. The debt-to-equity ratio of 1.3 represents moderate leverage for a service-based operation, while the current ratio of 1.1 provides limited liquidity cushion.
Relative to peers AJG, BRO, and RYAN, Marsh & McLennan's scale advantages manifest in superior ROE generation, though recent price momentum lags. The company's operating margin of 21.7% establishes it as a high-efficiency operator within specialized risk and human capital consulting segments.
Analysis updated monthly based on systematic screening of fundamentals, profitability, growth, and peer positioning.